These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 6369734)

  • 21. Clinical experience with insulin-glycerol solution in an implantable pump.
    Rupp WM; Rohde TD; Wigness BD; Blackshear PJ; Buchwald H
    Trans Am Soc Artif Intern Organs; 1983; 29():492-5. PubMed ID: 6369731
    [No Abstract]   [Full Text] [Related]  

  • 22. Effects of a novel short-term continuous subcutaneous insulin infusion program evaluated by continuous glucose monitoring on young adult type 1 diabetic patients in Taiwan.
    Lin CH; Huang CH; Tsai JS; Hsieh SH; Sun JH; Huang BY; Huang MJ; Huang YY
    Endocr J; 2011; 58(10):835-40. PubMed ID: 21828934
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A randomized trial of continuous subcutaneous insulin infusion and intensive injection therapy in type 1 diabetes for patients with long-standing poor glycemic control.
    DeVries JH; Snoek FJ; Kostense PJ; Masurel N; Heine RJ;
    Diabetes Care; 2002 Nov; 25(11):2074-80. PubMed ID: 12401759
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Continuous subcutaneous insulin infusion in type 1 diabetic Saudi children. A comparison with conventional insulin therapy.
    Bin-Abbas BS; Sakati NA; Raef H; Al-Ashwal AA
    Saudi Med J; 2005 Jun; 26(6):918-22. PubMed ID: 15983674
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Multiple daily self-glucose monitoring: its essential role in long-term glucose control in insulin-dependent diabetic patients treated with pump and multiple subcutaneous injections.
    Schiffrin A; Belmonte M
    Diabetes Care; 1982; 5(5):479-84. PubMed ID: 6765224
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of treatment with continuous subcutaneous insulin infusion versus multiple daily insulin injections with bolus calculator in patients with type 1 diabetes.
    Pérez-García L; Goñi-Iriarte MJ; García-Mouriz M
    Endocrinol Nutr; 2015; 62(7):331-7. PubMed ID: 26234808
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association of Insulin Pump Therapy vs Insulin Injection Therapy With Severe Hypoglycemia, Ketoacidosis, and Glycemic Control Among Children, Adolescents, and Young Adults With Type 1 Diabetes.
    Karges B; Schwandt A; Heidtmann B; Kordonouri O; Binder E; Schierloh U; Boettcher C; Kapellen T; Rosenbauer J; Holl RW
    JAMA; 2017 Oct; 318(14):1358-1366. PubMed ID: 29049584
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Education on sensor-augmented pump use improves glucose control in type 1 diabetic patients.
    Thielen V; Place J; Gerbaud S; Scheen A; Bringer J; Renard E
    Diabetes Metab; 2010 Apr; 36(2):170-1. PubMed ID: 20153675
    [No Abstract]   [Full Text] [Related]  

  • 29. Beneficial effects of continuous subcutaneous insulin infusion in older patients with long-standing type 1 diabetes.
    Rizvi AA; Petry R; Arnold MB; Chakraborty M
    Endocr Pract; 2001; 7(5):364-9. PubMed ID: 11585372
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Maternal and perinatal outcomes in pregnant women with type 1 diabetes treated with continuous subcutaneous insulin infusion and real time continuous glucose monitoring in two specialized centers in Medellin, Colombia.
    Restrepo-Moreno M; Ramírez-Rincón A; Hincapié-García J; Palacio A; Monsalve-Arango C; Aristizabal-Henao N; Restrepo-Zapata C; Botero-Arango JF
    J Matern Fetal Neonatal Med; 2018 Mar; 31(6):696-700. PubMed ID: 28264604
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Continuous subcutaneous insulin infusion versus injection therapy: a randomized cross-over trial under usual diabetic clinic conditions.
    Marshall SM; Home PD; Taylor R; Alberti KG
    Diabet Med; 1987; 4(6):521-5. PubMed ID: 2962807
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Perceptions in Type 1 Diabetes Mellitus with or Without the Use of Insulin Pump: An Online Study.
    Benioudakis ES
    Curr Diabetes Rev; 2020; 16(8):874-880. PubMed ID: 31057119
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Continuous single-rate long-term insulin infusion using a totally implantable pump.
    Chute EP; Rupp WM; Rohde TD; Goldenberg FJ; Bordewich PH; Hitchcock CR; Blackshear PJ; Buchwald H
    Trans Am Soc Artif Intern Organs; 1984; 30():387-9. PubMed ID: 6533912
    [No Abstract]   [Full Text] [Related]  

  • 34. A comparison of multiple daily insulin therapy with continuous subcutaneous insulin infusion therapy in adolescents with type 1 diabetes mellitus: a single-center experience from Turkey.
    Abaci A; Atas A; Unuvar T; Demir K; Bober E; Büyükgebiz A
    J Pediatr Endocrinol Metab; 2009 Jun; 22(6):539-45. PubMed ID: 19694201
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Insulin pump with glucose sensor in type 1 diabetes. But the artificial pancreas is still far off].
    Moberg E
    Lakartidningen; 2010 Dec 8-14; 107(49):3120-1. PubMed ID: 21284143
    [No Abstract]   [Full Text] [Related]  

  • 36. Reducing glucose variability with continuous subcutaneous insulin infusion is associated with reversal of axonal dysfunction in type 1 diabetes mellitus.
    Kamel J; Loh M; Cook M; MacIsaac RJ; Roberts LJ
    Muscle Nerve; 2020 Jan; 61(1):44-51. PubMed ID: 31613996
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Epidemiological characterization of diabetic patients on therapy with continuous subcutaneous insulin infusion and continuous glucose monitoring in real time.
    Aristizábal N; Ramírez A; Hincapié-García J; Laiton E; Aristizábal C; Cuesta D; Monsalve C; Hincapié G; Zapata E; Abad V; Delgado MR; Torres JL; Palacio A; Botero J;
    Endocrinol Nutr; 2015 Nov; 62(9):451-7. PubMed ID: 26521154
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Experience with intraperitoneal insulin infusion from implantable programmable systems in type 1 (insulin-dependent) diabetes mellitus previously treated by external pumps.
    Renard E; Lauton D; Bonifacj C; Costalat G; Jacques D; Bringer J; Jaffiol C
    Diabete Metab; 1993; 19(4):364-71. PubMed ID: 8293863
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Feasibility of strict diabetes control in insulin-dependent diabetic adolescents.
    Schiffrin A; Desrosiers M; Moffatt M; Belmonte MM
    J Pediatr; 1983 Oct; 103(4):522-7. PubMed ID: 6352883
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The management of severe brittle diabetes with "Infusaid" implantable pumps.
    Gill GV; Husband DJ; Wright PD; Sharpe G; Taylor R; Walford S; Marshall SM; Alberti KG
    Diabetes Res; 1986 Mar; 3(3):135-7. PubMed ID: 3709039
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.